Thus, evidence to date suggests that microbial SCFAs could directly impact the obesity phenotype, potentially by modulating adipocyte metabolism via GPR41 or GPR43. The gene discussed is FFAR2; the disease is obesity due to melanocortin 4 receptor deficiency.